Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Linton

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
JCO Precision Oncology|July 10, 2025
Prognostic Role of <i>MTAP</i> Loss in CholangiocarcinomaJames Lyon, Soravis Osataphan, Vaibhav Birda, et al.
Cancers|August 10, 2024
Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-PaclitaxelRodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 25, 2022
Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation modelMary Linton B Peters, Andrew Eckel, Anna Lietz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2023
Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C IndividualsJagpreet Chhatwal, Ali Hajjar, Peter P Mueller, et al.
Neurosurgery|August 27, 2011
Limbic and motor function comparison of deep brain stimulation of the zona incerta and subthalamic nucleusAnthony M Burrows, Paula D Ravin, Peter Novak, et al.
JCO Oncology Practice|December 12, 2023
Cost-Effectiveness Analysis of Screening for Pancreatic Cancer Among High-Risk PopulationsMary Linton B Peters, Andrew Eckel, Claudia L Seguin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, et al.
Cancer Medicine|February 9, 2021
Time to SARS-CoV-2 clearance among patients with cancer and COVID-19Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, et al.
Cancer Medicine|July 1, 2023
Updated COVID-19 clearance time among patients with cancer in the Delta and Omicron wavesZachary M Avigan, Rodrigo Paredes, Leora S Boussi, et al.
The Oncologist|March 13, 2020
Fluoropyrimidine-Associated Cardiotoxicity: A Retrospective Case-Control StudyInbar Raber, Sarah Warack, Jaya Kanduri, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
JCO Precision Oncology|July 10, 2025
Prognostic Role of <i>MTAP</i> Loss in CholangiocarcinomaJames Lyon, Soravis Osataphan, Vaibhav Birda, et al.
Cancers|August 10, 2024
Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-PaclitaxelRodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 25, 2022
Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation modelMary Linton B Peters, Andrew Eckel, Anna Lietz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2023
Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C IndividualsJagpreet Chhatwal, Ali Hajjar, Peter P Mueller, et al.
Neurosurgery|August 27, 2011
Limbic and motor function comparison of deep brain stimulation of the zona incerta and subthalamic nucleusAnthony M Burrows, Paula D Ravin, Peter Novak, et al.
JCO Oncology Practice|December 12, 2023
Cost-Effectiveness Analysis of Screening for Pancreatic Cancer Among High-Risk PopulationsMary Linton B Peters, Andrew Eckel, Claudia L Seguin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, et al.
Cancer Medicine|February 9, 2021
Time to SARS-CoV-2 clearance among patients with cancer and COVID-19Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, et al.
Cancer Medicine|July 1, 2023
Updated COVID-19 clearance time among patients with cancer in the Delta and Omicron wavesZachary M Avigan, Rodrigo Paredes, Leora S Boussi, et al.
The Oncologist|March 13, 2020
Fluoropyrimidine-Associated Cardiotoxicity: A Retrospective Case-Control StudyInbar Raber, Sarah Warack, Jaya Kanduri, et al.
Pageof 5